Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ample Medical was a medical device company based in Foster City, California, that specialized in the development of transcatheter mitral valve repair technologies. Founded in 2004 by Dr. Amir Belson, the company focused on creating a percutaneous solution for treating mitral regurgitation, a condition where the heart's mitral valve does not close tightly. Their flagship technology was designed to allow clinicians to repair the valve through a catheter-based approach, significantly reducing the invasiveness compared to traditional open-heart surgery. The company's innovative approach to structural heart disease attracted significant venture capital and industry interest. In April 2007, Medtronic acquired Ample Medical for approximately $50 million to integrate its technology into Medtronic's structural heart division. This acquisition was part of a broader industry trend toward developing less invasive treatments for valvular heart disease.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ample Medical.